ICGastrIndocyanine Green for Enhanced Lymph Node Dissection in Gastric Cancer Surgery

This clinical trial focuses on improving the surgical treatment of gastric cancer by using a special dye called indocyanine green (ICG). The goal is to enhance the removal of lymph nodes, which are small glands that play a crucial role in the spread of cancer. Proper removal of these lymph nodes can significantly impact the survival and recovery of patients with gastric cancer. Traditionally, these surgeries are done without advanced imaging, but using ICG might help surgeons see and remove more lymph nodes, which is crucial for better treatment outcomes and preventing cancer recurrence. In this study, eligible patients with newly diagnosed stomach cancer will receive an injection of ICG dye around their tumor before undergoing surgery. This procedure helps identify which lymph nodes to remove more effectively. The trial will measure how many lymph nodes are removed using this method and assess any side effects or complications. The hope is that using ICG will increase the number of lymph nodes removed during surgery, leading to better management of the cancer and reducing the chances of it coming back. Participants will be closely monitored for any side effects from the dye or the surgery itself.